Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy
dc.contributor.author | Carrasco Padilla, Carlos | |
dc.contributor.author | Hernaiz Esteban, Alicia | |
dc.contributor.author | Álvarez Vallina, Luis | |
dc.contributor.author | Aguilar Sopeña, Óscar | |
dc.contributor.author | Roda Navarro, Pedro | |
dc.date.accessioned | 2023-06-22T11:20:46Z | |
dc.date.available | 2023-06-22T11:20:46Z | |
dc.date.issued | 2022-12-30 | |
dc.description.abstract | T cell-redirecting strategies have emerged as effective cancer immunotherapy approaches. Bispecific antibodies (bsAbs) are designed to specifically recruit T cells to the tumor microenvironment and induce the assembly of the immunological synapse (IS) between T cells and cancer cells or antigen-presenting cells. The way that the quality of the IS might predict the effectiveness of T cell-redirecting strategies, including those mediated by bsAbs or by chimeric antigen receptors (CAR)-T cells, is currently under discussion. Here we review the organization of the canonical IS assembled during natural antigenic stimulation through the T cell receptor (TCR) and to what extent different bsAbs induce T cell activation, canonical IS organization, and effector function. Then, we discuss how the biochemical parameters of different formats of bsAbs affect the effectivity of generating an antigen-induced canonical IS. Finally, the quality of the IS assembled by bsAbs and monoclonal antibodies or CAR-T cells are compared, and strategies to improve bsAb-mediated T cell-redirecting strategies are discussed. | |
dc.description.department | Depto. de Inmunología, Oftalmología y ORL | |
dc.description.faculty | Fac. de Medicina | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Ministerio de Ciencia e Innovación (España) | |
dc.description.sponsorship | Instituto de Salud Carlos III | |
dc.description.sponsorship | Fundación CRIS del Cáncer | |
dc.description.sponsorship | Asociación Española Contra el Cáncer | |
dc.description.sponsorship | Fundación “La Caixa” | |
dc.description.sponsorship | Fundación de Investigación Biomédica 12 de Octubre | |
dc.description.status | pub | |
dc.eprint.id | https://eprints.ucm.es/id/eprint/78428 | |
dc.identifier.doi | 10.3390/pharmaceutics15010132 | |
dc.identifier.issn | 1999-4923 | |
dc.identifier.officialurl | https://doi.org/10.3390/pharmaceutics15010132 | |
dc.identifier.relatedurl | https://www.mdpi.com/journal/pharmaceutics | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/72336 | |
dc.issue.number | 1 | |
dc.journal.title | Pharmaceutics | |
dc.language.iso | eng | |
dc.page.initial | 132 | |
dc.publisher | MDPI | |
dc.relation.projectID | PID2020-115444GB-I00 ; PID2020-117323RB-100 y PDC2021-121711-100 | |
dc.relation.projectID | DTS20/00089 | |
dc.relation.projectID | FCRIS-2021-0090 | |
dc.relation.projectID | PROYE19084ALVA | |
dc.relation.projectID | HR21-00761 IL7R_LungCan | |
dc.relation.projectID | Programa Investiga (2022-0082) | |
dc.rights | Atribución 3.0 España | |
dc.rights.accessRights | open access | |
dc.rights.uri | https://creativecommons.org/licenses/by/3.0/es/ | |
dc.subject.cdu | 612.017 | |
dc.subject.cdu | 616-006.04 | |
dc.subject.keyword | IS | |
dc.subject.keyword | T cell | |
dc.subject.keyword | Immunotherapy | |
dc.subject.keyword | bsAb | |
dc.subject.keyword | CAR | |
dc.subject.keyword | TCR | |
dc.subject.ucm | Medicina | |
dc.subject.ucm | Inmunología | |
dc.subject.ucm | Oncología | |
dc.subject.unesco | 32 Ciencias Médicas | |
dc.subject.unesco | 2412 Inmunología | |
dc.subject.unesco | 3201.01 Oncología | |
dc.title | Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy | |
dc.type | journal article | |
dc.volume.number | 15 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 395f5345-8bac-41a2-a014-53c44bf97360 | |
relation.isAuthorOfPublication.latestForDiscovery | 395f5345-8bac-41a2-a014-53c44bf97360 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- pharmaceutics-15-00132.pdf
- Size:
- 894.36 KB
- Format:
- Adobe Portable Document Format